NR5A2 and pulmonary arterial hypertension: As shown in a prior analysis (Perera et al. 2003), exclusion of CPF from the model did not affect the estimated size of PAH effect (change in PAH effect < 3%), indicating that CPF is neither a significant effect modifier nor a confounder.